These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4955698)

  • 21. [Isolation and properties of interferon from chicken embryo fibroblasts and mouse brain infected with the eastern equine encephalomyelitis virus (EEE)].
    Ognianov D; Fernández A
    Zentralbl Veterinarmed B; 1972 Feb; 19(2):94-8. PubMed ID: 5050030
    [No Abstract]   [Full Text] [Related]  

  • 22. Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus.
    Barabé ND; Rayner GA; Christopher ME; Nagata LP; Wu JQ
    Vaccine; 2007 Aug; 25(33):6271-6. PubMed ID: 17630056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CROSS-PROTECTION IN ANIMALS INFECTED WITH GROUP A ARBOVIRUSES.
    HEARN HJ; RAINEY CT
    J Immunol; 1963 May; 90():720-4. PubMed ID: 14053290
    [No Abstract]   [Full Text] [Related]  

  • 25. [Replicative complex of the Venezuelan equine encephalomyelitis virus].
    Zhdanov VM; Ershov FI; Uryvaev LV
    Dokl Akad Nauk SSSR; 1969 Dec; 189(6):1382-4. PubMed ID: 5407981
    [No Abstract]   [Full Text] [Related]  

  • 26. NATURAL OVERWINTERING HOSTS OF THE VIRUS OF WESTERN EQUINE ENCEPHALITIS.
    GEBHARDT LP; STANTON GJ; HILL DW; COLLETT GC
    N Engl J Med; 1964 Jul; 271():172-7. PubMed ID: 14158354
    [No Abstract]   [Full Text] [Related]  

  • 27. Eastern equine encephalomyelitis vaccine prepared in cell cultures.
    LOWENTHAL JP; BERMAN S; GROGAN EW
    Science; 1961 Aug; 134(3478):565-6. PubMed ID: 13763845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental work with the virus of Venezuelan encephalitis (VEE)].
    Briceño Rossi AL
    Rev Venez Sanid Asist Soc; 1964 Sep; 29(3):410-24. PubMed ID: 5843185
    [No Abstract]   [Full Text] [Related]  

  • 29. Gamma-irradiated Venezuelan equine encephalitis vaccines.
    Reitman M; Tribble HR; Green L
    Appl Microbiol; 1970 May; 19(5):763-7. PubMed ID: 5463575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of DNA vaccination against western equine encephalitis virus infection.
    Nagata LP; Hu WG; Masri SA; Rayner GA; Schmaltz FL; Das D; Wu J; Long MC; Chan C; Proll D; Jager S; Jebailey L; Suresh MR; Wong JP
    Vaccine; 2005 Mar; 23(17-18):2280-3. PubMed ID: 15755611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation in donkeys on an inactivated Venezuelan equine encephalitis vaccine.
    Villasmil DP; De Siger J; Barrientos MP; Mussgay M; Mackenzie RB
    Zentralbl Veterinarmed B; 1975 Mar; 22(2):162-8. PubMed ID: 1130149
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the Venezuelan equine encephalomyelitis virus].
    Briceño Rossi AL
    Rev Venez Sanid Asist Soc; 1964 Sep; 29(3):351-3. PubMed ID: 5843182
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on Japanese B encephalitis virus vaccines from tissue culture. X. Characterization of a 37 degreeC passage line attenuated strain of OCT-541 virus.
    French GR; Hammon WM
    J Immunol; 1969 Dec; 103(6):1260-7. PubMed ID: 4311921
    [No Abstract]   [Full Text] [Related]  

  • 34. Mouse potency assay for Western equine encephalomyelitis vaccines.
    Robinson DM; Berman S; Lowenthal JP
    Appl Microbiol; 1972 Jan; 23(1):104-7. PubMed ID: 5059614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Various genetic characteristics of apathogenic mutants of Western equine encephalitis].
    Zasukhina GD
    Vopr Virusol; 1967; 12(1):65-8. PubMed ID: 5602534
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of Western equine encephalomyelitis virus. I. Genetic markers of virus variants obtained by formaldehyde treatment and ultraviolet irradiation.
    Zasukhina GD; Israelyan AA; Levkovich EN
    Acta Virol; 1967 Jan; 11(1):13-9. PubMed ID: 4382128
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of the host system on the properties of Venezuelan equine encephalomyelitis virus.
    Hrusková J; Danes L; Kliment V
    Acta Virol; 1970 Jul; 14(4):272-8. PubMed ID: 4394182
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
    Turell MJ; O'Guinn ML; Parker MD
    Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.